Jiangsu Nanfang Medical (603880) — Net Asset Quality Index
Jiangsu Nanfang Medical (603880) has a Net Asset Quality Index of 18.7% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥874.85 Million minus total liabilities of CN¥711.34 Million yields net assets of CN¥163.51 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Jiangsu Nanfang Medical (603880) financial obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Jiangsu Nanfang Medical Net Asset Quality Index Over Time (2012–2025)
This chart shows how Jiangsu Nanfang Medical's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the index stands at 18.7%, representing net assets of CN¥163.51 Million against total assets of CN¥874.85 Million CNY. For live market cap and overall valuation, see 603880 market cap overview.
Annual Net Asset Quality Index for Jiangsu Nanfang Medical (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Jiangsu Nanfang Medical from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Jiangsu Nanfang Medical (603880) strategic investment index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 19.5% | CN¥181.17 Million | CN¥927.94 Million | CN¥746.77 Million | ▼ -7.4 pp |
| 2024 | 26.9% | CN¥284.41 Million | CN¥1.06 Billion | CN¥772.14 Million | ▼ -10.2 pp |
| 2023 | 37.1% | CN¥474.22 Million | CN¥1.28 Billion | CN¥803.11 Million | ▼ -5.5 pp |
| 2022 | 42.6% | CN¥621.48 Million | CN¥1.46 Billion | CN¥835.75 Million | ▼ -10.4 pp |
| 2021 | 53.0% | CN¥654.90 Million | CN¥1.24 Billion | CN¥580.29 Million | ▼ -12.3 pp |
| 2020 | 65.3% | CN¥700.80 Million | CN¥1.07 Billion | CN¥371.84 Million | ▲ +0.1 pp |
| 2019 | 65.3% | CN¥567.52 Million | CN¥869.60 Million | CN¥302.08 Million | ▼ -1.0 pp |
| 2018 | 66.2% | CN¥560.04 Million | CN¥845.81 Million | CN¥285.78 Million | ▲ +0.9 pp |
| 2017 | 65.3% | CN¥537.57 Million | CN¥822.96 Million | CN¥285.40 Million | ▲ +15.6 pp |
| 2016 | 49.7% | CN¥256.69 Million | CN¥516.55 Million | CN¥259.87 Million | ▲ +2.7 pp |
| 2015 | 47.0% | CN¥222.51 Million | CN¥473.37 Million | CN¥250.86 Million | ▼ -1.3 pp |
| 2014 | 48.3% | CN¥210.90 Million | CN¥437.01 Million | CN¥226.10 Million | ▲ +3.1 pp |
| 2013 | 45.2% | CN¥168.57 Million | CN¥373.35 Million | CN¥204.78 Million | ▲ +13.2 pp |
| 2012 | 32.0% | CN¥121.38 Million | CN¥379.79 Million | CN¥258.41 Million | — |